| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 24.07 Billion | USD 64.86 Billion | 10.42% | 2024 |
FrequentlyAsked Questions
The global dermatologicals market is expected to grow due to increasing skin disease prevalence, rising cosmetic dermatology demand, and innovation in topical treatments.
According to a study, the global dermatologicals market size was worth around USD 24.07 Billion in 2024 and is expected to reach USD 64.86 Billion by 2034.
The global dermatologicals market is expected to grow at a CAGR of 10.42% during the forecast period.
North America is expected to dominate the dermatologicals market over the forecast period.
Leading players in the global dermatologicals market include AbbVie, Amgen, Galderma, GlaxoSmithKline, Johnson & Johnson, Novartis, Eli Lilly, Sun Pharmaceutical Industries, Almirall, Bausch Health, among others.
The report explores crucial aspects of the dermatologicals market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients